FindTrial
Sign In

A randomized placebo-controlled trial of introdiscal methlene blue injection for the treatment of chronic discogenic low back pain

A randomized placebo-controlled trial of introdiscal methlene blue injection for the treatment of chronic discogenic low back pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-07000017
Enrollment
Unknown
Registered
2007-07-07
Start date
2003-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discogenic low back pain

Interventions

control group:discography ang introdiscal injection with 0.9% sodium chloride
one of them lost followup
treatment group:discography and introdiscal injection with 1%methylene blue

Sponsors

304th Hospital of PLA,The Armed Police General Hospital, People's Hospital of Sanhe and Victory Hospital of Dongying
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults with chronic discogenic low back pain without radiculopathy, the interval of pyramids normal or slightly narrow tested by X-ray, without surgical history for pyramids, no improvement in the physical therapy or non-steroids drugs treatment long than six months.

Exclusion criteria

Exclusion criteria: Lumbar disc herniation, lumbar canal stenosis, neurologic disease, tumor, or infection were excluded

Design outcomes

Primary

MeasureTime frame
Function scores;Pain scores;No improvement;—

Countries

China

Contacts

Public ContactBaogan Peng
pengbaogan@163.com+86 010 88276611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026